FAT1 and glioblastoma: The data obtained within The Cancer Genome Atlas Program revealed that FAT1-inactivating mutations account for 1% of GBM cases, whereas approximately 20% of the cases are reported to be related to a copy number loss of FAT1 in GBMs.